Arginine

Arginine

SCHEMBL11905098

C[C@H](N)C(=O)O.C[C@H](NC1CCCCC1)C(=O)O.N=C(N)NCCC[C@H](N)C(=O)O

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACE

The experimentally established mechanism targets of Arginine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ OTC P00480 1/20 0.37
▸ NOS3 P29474 1/20 0.36
▸ NOS1 P29475 1/20 0.36
▸ NOS2 P35228 1/20 0.36
▸ DDAH1 O94760 1/20 0.36
▸ EPHX2 P34913 5/20 0.35
▸ SMN1; SMN2 Q16637 3/20 0.35
▸ GAA P10253 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ NPY4R P50391 3/20 0.34
▸ NPY1R P25929 2/20 0.34
▸ NPY2R P49146 2/20 0.34
▸ NPY5R Q15761 2/20 0.34
▸ EPHX1 P07099 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Arginine SCHEMBL15110976 0.98 OTC (0.39) OTCNOS3NOS1NOS2DDAH1
Arginine SCHEMBL27539177 0.92 OTC (0.32) OTCNOS3NOS1NOS2DDAH1
Arginine SCHEMBL11905345 0.87 PRCP (0.35) OTCNOS3NOS1NOS2DDAH1
Arginine SCHEMBL11905875 0.87 SMN1; SMN2 (0.34) OTCNOS3NOS1NOS2DDAH1
Arginine SCHEMBL244720 0.84 OTC (0.43) OTCNOS3NOS1NOS2DDAH1
Arginine SCHEMBL9754275 0.83 OTC (0.50) OTCNOS3NOS1NOS2DDAH1
Arginine SCHEMBL5544125 0.83 OTC (0.50) OTCNOS3NOS1NOS2DDAH1
Arginine SCHEMBL1821002 0.83 OTC (0.50) OTCNOS3NOS1NOS2DDAH1
Arginine SCHEMBL5544129 0.83 OTC (0.50) OTCNOS3NOS1NOS2DDAH1
Arginine SCHEMBL5312506 0.83 OTC (0.50) OTCNOS3NOS1NOS2DDAH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9091700-B2 Modified peptide substrate MCMASTER UNIVERSITY (CA) 2015-07-28 — — US claimed
US-20120208225-A1 MODIFIED PEPTIDE SUBSTRATE THE UNIVERSITY OF MELBOURNE (AU) 2012-08-16 — — US claimed
US-10131932-B2 Method for assaying a protease MCMASTER UNIVERSITY 2018-11-20 — — US disclosed
EP-3047033-B1 METHOD FOR ASSAYING A PROTEASE UNIV MCMASTER (CA) 2018-08-22 — — EP disclosed
US-20160326569-A1 METHOD FOR ASSAYING A PROTEASE MCMASTER UNIVERSITY (CA) 2016-11-10 — — US disclosed
EP-3047033-A1 METHOD FOR ASSAYING A PROTEASE Mcmaster University (CA) 2016-07-27 — — EP disclosed
US-9091700-B2 Modified peptide substrate MCMASTER UNIVERSITY (CA) 2015-07-28 — — US disclosed
WO-2015039211-A1 METHOD FOR ASSAYING A PROTEASE MCMASTER UNIVERSITY (CA) 2015-03-26 — — WO disclosed
US-20120208225-A1 MODIFIED PEPTIDE SUBSTRATE THE UNIVERSITY OF MELBOURNE (AU) 2012-08-16 — — US disclosed
Send feedback